共 173 条
- [1] Richardson S(2020)Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area JAMA 323 2052-1720
- [2] Hirsch JS(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-1681
- [3] Narasimhan M(2020)Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19 Circ Res 126 1671-2448
- [4] Crawford JM(2020)Renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 N Engl J Med 382 2441-84
- [5] McGinn T(2021)Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19 JAMA 325 254-1412
- [6] Davidson KW(2021)Exploring drugs and vaccines associated with altered risks and severity of COVID-19: a UK Biobank cohort study of all ATC level-4 drug categories reveals repositioning opportunities Pharmaceutics 13 1514-845
- [7] Barnaby DP(2021)Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching Gut 70 76-2516
- [8] Becker LB(2022)Assessment of proton-pump inhibitor use, race, socioeconomic status, and mortality in individuals with COVID-19 Eur J Gastroenterol Hepatol 34 239-207
- [9] Chelico JD(2020)Proton pump inhibitor use is associated with increased risk of severity and mortality from coronavirus disease 2019 (COVID-19) infection Dig Liver Dis 52 1410-797
- [10] Cohen SL(2015)Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients Intensive Care Med 41 833-381